Suayib Yalcin Selected Research

Suayib Yalcin Research Topics

Disease

41	Neoplasms (Cancer) 03/2024 - 12/2002
14	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 03/2003
10	Pancreatic Neoplasms (Pancreatic Cancer) 04/2024 - 01/2002
10	Neoplasm Metastasis (Metastasis) 03/2024 - 12/2002
8	Adenocarcinoma 01/2021 - 01/2002
5	Disease Progression 03/2024 - 11/2010
5	Colonic Neoplasms (Colon Cancer) 05/2023 - 01/2019
4	Malnutrition (Nutritional Deficiencies) 04/2024 - 11/2019
4	Stomach Neoplasms (Stomach Cancer) 12/2023 - 09/2009
4	Carcinoma (Carcinomatosis) 01/2021 - 01/2005
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 05/2020 - 05/2011
3	Inflammation (Inflammations) 04/2024 - 04/2021
3	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 01/2020
3	Rectal Neoplasms (Rectal Cancer) 05/2023 - 01/2012
3	Liver Neoplasms (Liver Cancer) 01/2023 - 01/2020
3	Renal Cell Carcinoma (Grawitz Tumor) 08/2022 - 01/2019
2	Breast Neoplasms (Breast Cancer) 05/2023 - 01/2013
2	Acute Kidney Injury (Acute Renal Failure) 01/2023 - 06/2022
2	Cholangiocarcinoma 11/2022 - 01/2004
2	Hypoalbuminemia 09/2022 - 01/2022
2	Thyroid Neoplasms (Thyroid Cancer) 01/2015 - 01/2015
2	medullary Thyroid cancer 01/2015 - 01/2015
2	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2013 - 01/2007
1	Exanthema (Rash) 03/2024
1	Stomatitis 03/2024
1	Vascular Malformations 03/2024
1	Microsatellite Instability 12/2023
1	Cachexia 01/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023
1	Thromboembolism 09/2021
1	Brain Ischemia (Cerebral Ischemia) 01/2021
1	Pulmonary Embolism 01/2021
1	COVID-19 07/2020

Drug/Important Bio-Agent (IBA)

8	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 11/2003
7	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2022
6	PlatinumIBA 11/2023 - 01/2004
6	Cisplatin (Platino)FDA LinkGeneric 07/2015 - 01/2004
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2023 - 01/2013
5	Capecitabine (Xeloda)FDA Link 01/2023 - 01/2013
4	Biomarkers (Surrogate Marker)IBA 02/2024 - 01/2022
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2020 - 12/2014
4	Irinotecan (Camptosar)FDA LinkGeneric 01/2019 - 03/2003
4	Docetaxel (Taxotere)FDA Link 07/2015 - 01/2002
3	AlbuminsIBA 04/2024 - 01/2022
3	Proteins (Proteins, Gene)FDA Link 03/2024 - 01/2023
3	Bevacizumab (Avastin)FDA Link 11/2023 - 01/2013
3	Leucovorin (Folinic Acid)FDA Link 01/2019 - 11/2003
3	Sunitinib (Sutent)FDA Link 01/2015 - 05/2011
3	Imatinib Mesylate (Gleevec)FDA Link 01/2015 - 05/2011
2	Panitumumab (Vectibix)FDA Link 03/2024 - 12/2014
2	Tyrosine Kinase InhibitorsIBA 02/2024 - 01/2015
2	NivolumabIBA 11/2023 - 09/2021
2	human ERBB2 proteinIBA 05/2023 - 01/2021
2	ThrombospondinsIBA 08/2022 - 12/2021
2	Gemcitabine FDA Link 03/2020 - 08/2014
2	Monoclonal AntibodiesIBA 01/2019 - 12/2014
2	Cetuximab (Erbitux)FDA Link 12/2014 - 07/2010
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2013 - 04/2011
2	nilotinib FDA Link 11/2011 - 05/2011
2	Peptides (Polypeptides)IBA 04/2011 - 01/2007
2	Angiogenesis InhibitorsIBA 04/2011 - 01/2007
1	Serum AlbuminIBA 04/2024
1	Sirolimus (Rapamycin)FDA Link 03/2024
1	TOR Serine-Threonine KinasesIBA 03/2024
1	sotorasibIBA 03/2024
1	pembrolizumabIBA 12/2023
1	atezolizumabIBA 11/2023
1	folfirinoxIBA 11/2023
1	tributyl phosphate (TBP)IBA 07/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2023
1	Caveolin 1IBA 05/2023
1	AntigensIBA 04/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	Discoidin Domain ReceptorsIBA 01/2023
1	Complement System Proteins (Complement)IBA 02/2022
1	GlobulinsIBA 01/2022
1	AzoxymethaneIBA 12/2021
1	Circulating Tumor DNAIBA 12/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2021
1	Axitinib (AG 013736)IBA 09/2021
1	Tumor Biomarkers (Tumor Markers)IBA 04/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 03/2020

Therapy/Procedure

26	Drug Therapy (Chemotherapy) 04/2024 - 01/2002
21	Therapeutics 11/2023 - 11/2010
7	Immunotherapy 01/2023 - 08/2014
4	Adjuvant Chemotherapy 03/2024 - 01/2019
4	Radiotherapy 05/2023 - 01/2005
3	Metastasectomy 05/2023 - 01/2015
3	Chemoradiotherapy 01/2021 - 01/2005
2	Adjuvant Chemoradiotherapy 12/2023 - 01/2012
2	Neoadjuvant Therapy 05/2023 - 11/2013
2	Aftercare (After-Treatment) 04/2022 - 01/2020
1	Pancreaticoduodenectomy 11/2023
1	Precision Medicine 11/2022
1	Inappropriate Prescribing 06/2022
1	Polypharmacy 06/2022
1	Preoperative Exercise 04/2022
1	Gastrectomy 01/2021
1	Palliative Care (Palliative Therapy) 07/2020